1. Home
  2. EZGO vs NNVC Comparison

EZGO vs NNVC Comparison

Compare EZGO & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZGO Technologies Ltd.

EZGO

EZGO Technologies Ltd.

HOLD

Current Price

$1.29

Market Cap

28.4M

ML Signal

HOLD

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.49

Market Cap

30.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZGO
NNVC
Founded
2014
2005
Country
China
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.4M
30.6M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
EZGO
NNVC
Price
$1.29
$1.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
581.9K
323.0K
Earning Date
07-01-2025
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.85
52 Week High
$3.30
$2.23

Technical Indicators

Market Signals
Indicator
EZGO
NNVC
Relative Strength Index (RSI) 47.43 54.06
Support Level $1.17 $1.29
Resistance Level $1.32 $1.63
Average True Range (ATR) 0.10 0.12
MACD -0.02 0.03
Stochastic Oscillator 15.38 58.58

Price Performance

Historical Comparison
EZGO
NNVC

About EZGO EZGO Technologies Ltd.

EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: